Evidence map›Paper›PMID 38895619›Full record

ArticleFrontiers in pharmacology2024

PLGA and PDMS-based

Amr Maged, Mostafa Mabrouk, Hanzada T Nour El-Din, Lamyaa Osama, Shaimaa M Badr-Eldin, Azza A Mahmoud

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Targeted elimination of CD44RSC advances · 2026
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amr MagedPharmaceutics and Pharmaceutical Technology Department, Faculty of Pharmacy, Future University in Egypt, New Cairo, Egypt.
Mostafa MabroukRefractories, Ceramics and Building Materials Department, National Research Centre, Giza, Egypt.
Hanzada T Nour El-DinMicrobiology and Immunology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Lamyaa OsamaRefractories, Ceramics and Building Materials Department, National Research Centre, Giza, Egypt.
Shaimaa M Badr-EldinPharmaceutics Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Azza A MahmoudPharmaceutics and Pharmaceutical Technology Department, Faculty of Pharmacy, Future University in Egypt, New Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is among the most prevalent tumors worldwide. In this study,

Indexed as

antimicrobial activitybreast cancercopper-selenium nanoparticleshealthcarein-situ forming implantsPLGArosuvastatin calcium

Identifiers

PMID38895619
PMCPMC11183308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.